Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
0.667
-0.006 (-0.95%)
At close: Jun 26, 2026, 4:00 PM EDT
0.630
-0.036 (-5.46%)
After-hours: Jun 26, 2026, 7:43 PM EDT

Company Description

Envoy Medical, Inc., a hearing health company, provides medical technologies across the hearing loss spectrum.

The company’s medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire.

It offers personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants.

The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023.

Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

Envoy Medical, Inc.
Envoy Medical logo
Country United States
Founded 1995
Industry Medical Devices
Sector Healthcare
Employees 47
CEO Brent Lucas

Contact Details

Address:
4875 White Bear Parkway
White Bear Lake, Minnesota 55110
United States
Phone 877 900 3277
Website envoymedical.com

Stock Details

Ticker Symbol COCH
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001840877
CUSIP Number 29415V109
ISIN Number US29415V1098
Employer ID 86-1369123
SIC Code 3842

Key Executives

Name Position
Brent T. Lucas Esq. Chief Executive Officer and Director
Robert M. Potashnick Interim Chief Financial Officer and Principal Accounting Officer
Karin Simonson Vice President, General Counsel and Corporate Secretary

Latest SEC Filings

Date Type Title
Jun 25, 2026 8-K Current Report
Jun 16, 2026 EFFECT Notice of Effectiveness
Jun 12, 2026 POS AM Post-Effective amendments for registration statement
Jun 12, 2026 S-8 Securities to be offered to employees in employee benefit plans
May 22, 2026 8-K Current Report
May 18, 2026 8-K Current Report
May 15, 2026 SCHEDULE 13G Filing
May 14, 2026 SCHEDULE 13G Filing
May 11, 2026 SCHEDULE 13G/A Filing
May 11, 2026 10-Q Quarterly Report